(Q44784148)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

José M González-Navajas

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Laura Sempere

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rubén Francés

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Ana Gutiérrez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Michael Scharl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Ernst Holler

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Isabel Almenta

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

José Such

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Reiner Wiest

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Gerhard Rogler

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

272-280

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23376290%20AND%20SRC:MED&resulttype=core&format=json

Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

The evolving epidemiology of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

New IBD genetics: common pathways with other diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Innate and adaptive immunity through autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in Crohn's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Eating for good health: linking autophagy and phagocytosis in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

The molecular classification of the clinical manifestations of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Infliximab for the treatment of fistulas in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Individual medicine in inflammatory bowel disease: monitoring bioavailability, pharmacokinetics and immunogenicity of anti-tumour necrosis factor-alpha antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Therapeutic drug monitoring of biologics for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Conventional medical management of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

What is the optimal therapy for Crohn's disease: step-up or top-down?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557

Infliximab, azathioprine, or combination therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FGUTJNL-2012-303557